Latest News

Chemo-radionuclide therapy halts neuroendocrine cancer

Advanced cancer of the neuroendocrine system can lead to dismal prognoses, but a novel therapy is packing a punch by uniting powerful radionuclide treatment and chemotherapy drugs, revealed researchers. Neuroendocrine tumors (NETs) are those that develop within a multiplicity of organs throughout the body that have nerve cells and interact with the endocrine system through chemical signaling made possible with various hormones. These tumors usually develop along the intestines and lungs, but they can also be found in the pancreas and many other sites.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Youths who survive self-poisoning continue to be at risk of suicide for years

  • We are family: Adult support reduces youths' risk of violence exposure

  • Parents sound off on mobile device use by children

  • Some children lose autism diagnosis but still struggle

  • Serving healthy foods with a smile may entice students to eat better

  • Mental disorders don't predict future violence, study suggests

  • High radiotherapy dose improves prospects for children with brain cancer

  • Resilience, not abstinence, may help teens battle online risk

  • Glimpses of how the brain transforms sound

  • Connecting places causes mental maps to merge

  •